Boardroom Alpha
Meeting calendar
INVX · Annual meeting · Thursday, May 7, 2026

Innovex International Inc

8 nominees · 3 ballot items.

Elect three directors (Proposal 1); ratify PwC as independent auditors for 2026 (Proposal 2); and cast a non-binding advisory “say-on-pay” vote to approve executive compensation (Proposal 3).

Market cap
$1.8B
1Y TSR
+55.7%
Board grade
B-
Record date
Mar 13, 2026
Filing
DEF 14A
Meeting concluded · May 7, 2026

Follow how the vote landed and what changed on Innovex International Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of John V. Lovoi, Will Donnell and Angie Sedita as Class II directors to serve three-year terms expiring in 2029.

  2. 2

    Ratification of Appointment of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026.

  3. 3

    Advisory Vote to Approve Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy statement.

    More detail

    This advisory proposal asks shareholders to approve, on a non-binding basis, the Company’s disclosed executive compensation for its named executive officers. Management seeks this approval to validate its pay-for-performance program, which combines base salary, annual cash incentives tied to Adjusted EBITDA, and long-term equity awards (RSUs and performance units tied to TSR and ROCE) to align management incentives with stockholder value. The Compensation Committee and Board argue the program is market‑competitive, grounded in peer benchmarking and consultant support, and was calibrated based on 2025 performance (including Adjusted EBITDA achievement that produced partial bonus payouts) and strong prior shareholder support (≈98% in 2025). The vote is advisory and non-binding, so while approval signals stockholder endorsement and influences future compensation decisions, it does not compel contractual changes. Key governance context includes robust committee oversight, stock ownership and anti‑hedging policies, and severance/change-in-control protections; critics often view such protections and guaranteed minimum equity grants as potential excesses. The Company emphasizes its annual say-on-pay engagement, responsiveness to feedback, and continued shareholder engagement as mechanisms to address concerns. Given the Company’s recent merger activity and significant equity grants tied to long‑term TSR and ROCE metrics, the proposal offers investors a way to weigh short-term payouts against long-term alignment mechanisms. The Board recommends a FOR vote, citing alignment of compensation with performance and retention needs, while acknowledging the advisory nature of the vote and committing to consider the outcome in future compensation determinations.

Director elections

Nominees on the ballot8

Independent
Tenure on this board
21.2 yrs
Also a director at
Helix Energy Solutions Group Inc (HLX)Epsilon Energy Ltd (EPSN)
Benjamin M. Fink
Independent
Tenure on this board
New nominee
Ownership

Top institutional holders10

Latest 13F quarter
1BRANDES INVESTMENT PARTNERS, LP7.4%5,096,215$124M
2BlackRock, Inc.6.2%4,278,110$104M
3VANGUARD PORTFOLIO MANAGEMENT LLC3.9%2,677,894$65M
4DIMENSIONAL FUND ADVISORS LP3.7%2,522,430$62M
5WELLINGTON MANAGEMENT GROUP LLP3.5%2,436,858$59M
6VANGUARD CAPITAL MANAGEMENT LLC2.8%1,931,211$47M
7GAMCO INVESTORS, INC. ET AL2.5%1,734,693$42M
8STATE STREET CORP2.5%1,716,278$42M
9DRIEHAUS CAPITAL MANAGEMENT LLC2.2%1,536,309$37M
10BRANDES INVESTMENT PARTNERS, LP2.0%1,377,618$34M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Innovex International Inc 2026 annual meeting?
Innovex International Inc (INVX) holds its 2026 annual shareholder meeting on Thursday, May 7, 2026.
What is the record date for the Innovex International Inc 2026 meeting?
The record date for the Innovex International Inc 2026 meeting is Friday, March 13, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Innovex International Inc's 2026 meeting?
The board is presenting 8 director nominees at the Innovex International Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Innovex International Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Innovex International Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer